(Q35194349)

7 August 2017

1 reference

title

Safety of antidepressants in the elderly (English)

1 reference

7 August 2017

5

Anna Lembke

1 reference

7 August 2017

Barbara R Sommer

1

1 reference

7 August 2017

Howard Fenn

2

1 reference

7 August 2017

Peter Pompei

3

1 reference

7 August 2017

Charles DeBattista

4

1 reference

7 August 2017

Po Wang

6

1 reference

7 August 2017

Ben Flores

7

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Drug Safety

7 August 2017

published in

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

367-383

1 reference

7 August 2017

cites work

Aging and pharmacology

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Drug transporters revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Drug interactions with grapefruit juice: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

The emerging role of cytochrome P450 3A in psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Desipramine treatment of major depression in patients over 75 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Antidepressant drugs in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Conventional and new antidepressant drugs in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

A survey of prescribing practices for monoamine oxidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Central nervous system-active medications and risk for falls in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Cardiovascular effects of fluoxetine in depressed patients with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

A study of fluoxetine in obese elderly patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

An open-label trial of citalopram for major depression in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Fluvoxamine: safety profile in extensive post-marketing surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Clinically significant drug interactions with antidepressants in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Venlafaxine in neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.367

21 January 2018

Identifiers

DOI

10.1517/14740338.2.4.367

1 reference

7 August 2017

1 reference